IMC

1.18%

8.6¢ immuron limited

NASDAQ Public Offer, page-26

First 26 Last

Share
Profile

Follow
Davo28

176 Posts.

5

29/11/16

21:20

Post #: 20977322
Share

Originally posted by tarecq ↑

Hi @Pixie

As requested, a brief reflection on today's AGM are below.

All resolutions passed.

Travelan, in GP dollars I was impressed to learn that this asset is giving IMC $700k a year profit (vs aprox just $50k of profit a year a few years ago). Thumbs up from me, this is $700k a year (and growing) that IMC doesn't have to go and raise from the market. And, it's on the pharmacy shelves, it has a presence and it's doing its thing with minimal effort/investment needed.

The same can be said for Protectyn, but it's early days there and at this stage is only available via naturopaths/practitioners and is being managed by someone specifically appointed to manage that channel.

Will they throw more money at marketing these OTC products? Management were unanimous that the answer is NO. All hands are on the NASH deck- this is the big ticket item that will deliver the most value for shareholders in the short term and to invest effort and capital on inferior opportunities would not be fair to shareholders... Tobira was taken over for US$1.7b... after their product FAILED its phase II NASH trial!

So what's IMC worth if they deliver a successful phase II trial? We will find out Q1 next year. Recruitment is just about complete and will be done by first week of Jan at the latest.

The decision was made to deliver the interim results from the NASH trial Q1 next year vs the current quarter as the sample size will be larger and more statistically significant. Big pharma will look at the results more seriously.

Management advised that there will be a substantial increase in time and capital invested in promoting this company as the company is entering a phase now where there will be more newsflow and critical inflection points. They want IMC to be on everyone's radar at this juncture.

I thought there was a real sense of purpose amongst management, they are all on the same page, focused, and determined to make Immuron a success story.

The next 3 months will be massive. I left the AGM feeling very confident.

Expand

Thanks Tarecq for the AGM summary. Makes sense to focus on NASH given the size of market and lack of alternatives available. I'm looking forward to results released in the next 3-6months.

The only minor disappointment for me from the investor pack released today was the status of the anti infective portfolio. The animal studies on clostridium difficile are very compelling. It would be nice to progress this a bit faster.

Also, I'm looking forward to results released from the US army and navy. Was there much discussion at the AGM on the anti infective portfolio?

IMC Price at posting: 33.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Bitcoin investors need to know the risks

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

There are more pages in this discussion • 29 more messages in this thread...

First 26 Last

Add IMC (ASX) to my watchlist

(20min delay)
Last 8.6¢		Change 0.001(1.18%)		Mkt cap ! $19.60M

Open	High	Low	Value	Volume
8.5¢	8.6¢	8.5¢	$3.74K	43.81K

Buyers (Bids)

No.	Vol.	Price($)
3	87972	8.5¢

Sellers (Offers)

Price($)	Vol.	No.
8.7¢	11610	2

View Market Depth

No.	Vol.	Price($)
2	35804	0.085
1	35585	0.084
1	17857	0.083
1	10000	0.082
2	57388	0.081

Price($)	Vol.	No.
0.087	11610	2
0.089	703	1
0.094	164287	1
0.100	60500	2
0.105	27018	3

Last trade - 15.55pm 12/07/2024 (20 minute delay)

IMC (ASX) Chart

NASDAQ Public Offer, page-26

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Immutep reports strong response rate from immunotherapies treating carcinomas

Nimy to raise $1.21M to explore 'newsy' WA targets

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Bitcoin investors need to know the risks

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

NASDAQ Public Offer, page-26

Top Stories

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Immutep reports strong response rate from immunotherapies treating carcinomas

Nimy to raise $1.21M to explore 'newsy' WA targets

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Bitcoin investors need to know the risks

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News